Drug resistance hampers our capacity to roll back malaria (Q36201223)

12 August 2017

1 reference

title

Drug resistance hampers our capacity to roll back malaria (English)

1 reference

12 August 2017

0 references

1

Piero Olliaro

1 reference

PubMed ID

16032560

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Clinical Infectious Diseases

12 August 2017

1 reference

12 August 2017

41 Suppl 4

1 reference

12 August 2017

S247-57

1 reference

Malaria: Current status of control, diagnosis, treatment, and a proposed agenda for research and development

12 August 2017

1 reference

21 January 2018

1 reference

Combating malaria in Africa

21 January 2018

1 reference

A systematic overview of published antimalarial drug trials

21 January 2018

1 reference

The global distribution and population at risk of malaria: past, present, and future

21 January 2018

1 reference

The past, present and future of childhood malaria mortality in Africa

21 January 2018

1 reference

Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa

21 January 2018

1 reference

The global distribution of clinical episodes of Plasmodium falciparum malaria

21 January 2018

1 reference

Mode of action and mechanisms of resistance for antimalarial drugs

21 January 2018

1 reference

Antimalarial compounds: from bench to bedside

21 January 2018

1 reference

Why is it that antimalarial drug treatments do not always work?

21 January 2018

1 reference

Drug resistant falciparum malaria: clinical consequences and strategies for prevention.

21 January 2018

1 reference

Clinical status and implications of antimalarial drug resistance.

21 January 2018

1 reference

Modelling a predictable disaster: the rise and spread of drug-resistantmalaria

21 January 2018

1 reference

The evolution of multiple drug resistance in malaria parasites.

21 January 2018

1 reference

The evolution of drug-resistant malaria: the role of drug elimination half-life

21 January 2018

1 reference

Artesunate combinations for treatment of malaria: meta-analysis

21 January 2018

1 reference

Antimalarial drugs and the mosquito transmission of Plasmodium

21 January 2018

1 reference

Intercontinental spread of pyrimethamine-resistant malaria

21 January 2018

1 reference

Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America

21 January 2018

1 reference

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

21 January 2018

1 reference

Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials

21 January 2018

1 reference

Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum

21 January 2018

1 reference

Chloroquine-resistant malaria

21 January 2018

1 reference

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

21 January 2018

1 reference

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

21 January 2018

1 reference

P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates

21 January 2018

1 reference

Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins

21 January 2018

1 reference

Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites

21 January 2018

1 reference

Monitoring antimalarial drug resistance: making the most of the tools at hand

21 January 2018

1 reference

The assessment of antimalarial drug efficacy

21 January 2018

1 reference

The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment

21 January 2018

1 reference

The molecular epidemiology of malaria

21 January 2018

1 reference

In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up

21 January 2018

1 reference

Epidemiology of drug-resistant malaria

21 January 2018

1 reference

Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand

21 January 2018

1 reference

Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia

21 January 2018

1 reference

Combination therapy for malaria: the way forward?

21 January 2018

1 reference

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

21 January 2018

1 reference

Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa

21 January 2018

1 reference

Economic access to effective drugs for falciparum malaria

21 January 2018

1 reference

The economic and social burden of malaria

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/430785

1 reference

12 August 2017

1 reference

PubMed ID

16032560